Limited vaccine access for developing countries

This procedure addresses the challenges developing nations face in accessing essential vaccines. It focuses on overcoming barriers such as high costs, intellectual property restrictions, and distribution hurdles to ensure that life-saving medicines are available globally, regardless of a country's wealth.

This affects global health organizations, pharmaceutical companies, and governments in developing regions. The goal is to establish fairer distribution mechanisms and support local production of vaccines.